Sherlock Biosciences, IDT collaborate to manufacture CRISPR-based SARS-CoV-2 testing kits
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
The therascreen KRAS RGQ PCR Kit is a real-time, qualitative in vitro diagnostic test for the detection of 7 somatic mutations in the KRAS oncogene using a sample of DNA extracted from formalin-fixed, paraffin-embedded (FPPE) non-small cell lung cancer (NSCLC) tissue and colorectal cancer (CRC) tissue.
Rapid, label-free imaging and volumetric analysis via HT-2 microscope studies the 4D interaction dynamics of T cells and their targets in the immunological synapse for the first time
University of Missouri School of Medicine pilots Roche’s cloud-based NAVIFY Tumor Board solution to streamline & standardize data collection and presentation, enabling faster, better collaboration among oncology care teams
Learn how to obtain a detailed understanding of tumor growth using live-cell imaging of 3D cell models in our upcoming webinar
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
New lung cancer panel enables acceleration of routine, automated testing in pathology laboratories
Using circulating cell-free DNA to analyze pancreatic cancer
Interlab comparison demonstrates Circulogene’s blood-drop-volume liquid biopsy assay is fastest, most accurate process to date for tracking and treating cancer
Liquid biopsy test delivers high negative predictive value of 99.2% for bladder cancer
FLOWSCRIPT™ Platform Detects Genotypic and Phenotypic Markers Associated with HPV Infection and Cancer Progression